Hypoglycemie hyperinsulinemique persistante du nouveau-ne et du nourrisson

Translated title of the contribution: Persistent hypoglycaemia due to hyperinsulinism in newborns and infants

P. De Lonlay-Debeney, J. C. Fournet, D. Martin, F. Poggi, C. Dionisi Vicci, M. Spada, G. Touati, J. Rahier, F. Brunelle, C. Junien, J. J. Robert, C. Nihoul-Fékété, J. M. Saudubray

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Persistent hyperinsulinemic hypoglycaemia of infancy (PHHI) is the most frequent cause of hypoglycaemia in infancy. Clinical presentation is heterogeneous, with variable onset of hypoglycaemia and response to diazoxide, and presence of sporadic or familial forms. Underlying histopathological lesions can be focal or diffuse. Focal lesions are characterised by focal hyperplasia of pancreatic islet-like cells, whereas diffuse lesions implicate the whole pancreas. The distinction between the two forms is important because surgical treatment and genetic counselling are radically different. Focal lesions correspond to somatic defects which are totally cured by limited pancreatic resection, whereas diffuse lesions require a subtotal pancreatectomy exposing to high risk of diabetes mellitus. Diffuse lesions are due to functional abnormalities involving several genes and different transmission forms. Recessively inherited PHHI have been attributed to homozygote mutations for the beta-cell sulfonylurea receptor (SURI) or the inward-rectifying potassium-channel (Kir6.2) genes. Dominantly inherited PHHI can implicate the glucokinase gene, particularly when PHHI is associated with diabetes, the glutamate dehydrogenase gene when hyperammonaemia is associated, or another locus.

Original languageFrench
Pages (from-to)1347-1352
Number of pages6
JournalArchives de Pediatrie
Volume5
Issue number12
DOIs
Publication statusPublished - Dec 1998

Fingerprint

Congenital Hyperinsulinism
Hyperinsulinism
Hypoglycemia
Newborn Infant
Islets of Langerhans
Genes
Sulfonylurea Receptors
Hyperammonemia
Diazoxide
Glucokinase
Glutamate Dehydrogenase
Pancreatectomy
Potassium Channels
Genetic Counseling
Homozygote
Hyperplasia
Pancreas
Diabetes Mellitus
Mutation

Keywords

  • Adenoma, islet cell
  • Hyperinsulinism
  • Hypoglycemia
  • Infant
  • Islet of Langherans
  • Pancreas
  • Pancreatic diseases

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

De Lonlay-Debeney, P., Fournet, J. C., Martin, D., Poggi, F., Dionisi Vicci, C., Spada, M., ... Saudubray, J. M. (1998). Hypoglycemie hyperinsulinemique persistante du nouveau-ne et du nourrisson. Archives de Pediatrie, 5(12), 1347-1352. https://doi.org/10.1016/S0929-693X(99)80055-4

Hypoglycemie hyperinsulinemique persistante du nouveau-ne et du nourrisson. / De Lonlay-Debeney, P.; Fournet, J. C.; Martin, D.; Poggi, F.; Dionisi Vicci, C.; Spada, M.; Touati, G.; Rahier, J.; Brunelle, F.; Junien, C.; Robert, J. J.; Nihoul-Fékété, C.; Saudubray, J. M.

In: Archives de Pediatrie, Vol. 5, No. 12, 12.1998, p. 1347-1352.

Research output: Contribution to journalArticle

De Lonlay-Debeney, P, Fournet, JC, Martin, D, Poggi, F, Dionisi Vicci, C, Spada, M, Touati, G, Rahier, J, Brunelle, F, Junien, C, Robert, JJ, Nihoul-Fékété, C & Saudubray, JM 1998, 'Hypoglycemie hyperinsulinemique persistante du nouveau-ne et du nourrisson', Archives de Pediatrie, vol. 5, no. 12, pp. 1347-1352. https://doi.org/10.1016/S0929-693X(99)80055-4
De Lonlay-Debeney P, Fournet JC, Martin D, Poggi F, Dionisi Vicci C, Spada M et al. Hypoglycemie hyperinsulinemique persistante du nouveau-ne et du nourrisson. Archives de Pediatrie. 1998 Dec;5(12):1347-1352. https://doi.org/10.1016/S0929-693X(99)80055-4
De Lonlay-Debeney, P. ; Fournet, J. C. ; Martin, D. ; Poggi, F. ; Dionisi Vicci, C. ; Spada, M. ; Touati, G. ; Rahier, J. ; Brunelle, F. ; Junien, C. ; Robert, J. J. ; Nihoul-Fékété, C. ; Saudubray, J. M. / Hypoglycemie hyperinsulinemique persistante du nouveau-ne et du nourrisson. In: Archives de Pediatrie. 1998 ; Vol. 5, No. 12. pp. 1347-1352.
@article{5681fe51479d49beaa81286176df7d77,
title = "Hypoglycemie hyperinsulinemique persistante du nouveau-ne et du nourrisson",
abstract = "Persistent hyperinsulinemic hypoglycaemia of infancy (PHHI) is the most frequent cause of hypoglycaemia in infancy. Clinical presentation is heterogeneous, with variable onset of hypoglycaemia and response to diazoxide, and presence of sporadic or familial forms. Underlying histopathological lesions can be focal or diffuse. Focal lesions are characterised by focal hyperplasia of pancreatic islet-like cells, whereas diffuse lesions implicate the whole pancreas. The distinction between the two forms is important because surgical treatment and genetic counselling are radically different. Focal lesions correspond to somatic defects which are totally cured by limited pancreatic resection, whereas diffuse lesions require a subtotal pancreatectomy exposing to high risk of diabetes mellitus. Diffuse lesions are due to functional abnormalities involving several genes and different transmission forms. Recessively inherited PHHI have been attributed to homozygote mutations for the beta-cell sulfonylurea receptor (SURI) or the inward-rectifying potassium-channel (Kir6.2) genes. Dominantly inherited PHHI can implicate the glucokinase gene, particularly when PHHI is associated with diabetes, the glutamate dehydrogenase gene when hyperammonaemia is associated, or another locus.",
keywords = "Adenoma, islet cell, Hyperinsulinism, Hypoglycemia, Infant, Islet of Langherans, Pancreas, Pancreatic diseases",
author = "{De Lonlay-Debeney}, P. and Fournet, {J. C.} and D. Martin and F. Poggi and {Dionisi Vicci}, C. and M. Spada and G. Touati and J. Rahier and F. Brunelle and C. Junien and Robert, {J. J.} and C. Nihoul-F{\'e}k{\'e}t{\'e} and Saudubray, {J. M.}",
year = "1998",
month = "12",
doi = "10.1016/S0929-693X(99)80055-4",
language = "Francese",
volume = "5",
pages = "1347--1352",
journal = "Archives de Pediatrie",
issn = "0929-693X",
publisher = "Elsevier Masson",
number = "12",

}

TY - JOUR

T1 - Hypoglycemie hyperinsulinemique persistante du nouveau-ne et du nourrisson

AU - De Lonlay-Debeney, P.

AU - Fournet, J. C.

AU - Martin, D.

AU - Poggi, F.

AU - Dionisi Vicci, C.

AU - Spada, M.

AU - Touati, G.

AU - Rahier, J.

AU - Brunelle, F.

AU - Junien, C.

AU - Robert, J. J.

AU - Nihoul-Fékété, C.

AU - Saudubray, J. M.

PY - 1998/12

Y1 - 1998/12

N2 - Persistent hyperinsulinemic hypoglycaemia of infancy (PHHI) is the most frequent cause of hypoglycaemia in infancy. Clinical presentation is heterogeneous, with variable onset of hypoglycaemia and response to diazoxide, and presence of sporadic or familial forms. Underlying histopathological lesions can be focal or diffuse. Focal lesions are characterised by focal hyperplasia of pancreatic islet-like cells, whereas diffuse lesions implicate the whole pancreas. The distinction between the two forms is important because surgical treatment and genetic counselling are radically different. Focal lesions correspond to somatic defects which are totally cured by limited pancreatic resection, whereas diffuse lesions require a subtotal pancreatectomy exposing to high risk of diabetes mellitus. Diffuse lesions are due to functional abnormalities involving several genes and different transmission forms. Recessively inherited PHHI have been attributed to homozygote mutations for the beta-cell sulfonylurea receptor (SURI) or the inward-rectifying potassium-channel (Kir6.2) genes. Dominantly inherited PHHI can implicate the glucokinase gene, particularly when PHHI is associated with diabetes, the glutamate dehydrogenase gene when hyperammonaemia is associated, or another locus.

AB - Persistent hyperinsulinemic hypoglycaemia of infancy (PHHI) is the most frequent cause of hypoglycaemia in infancy. Clinical presentation is heterogeneous, with variable onset of hypoglycaemia and response to diazoxide, and presence of sporadic or familial forms. Underlying histopathological lesions can be focal or diffuse. Focal lesions are characterised by focal hyperplasia of pancreatic islet-like cells, whereas diffuse lesions implicate the whole pancreas. The distinction between the two forms is important because surgical treatment and genetic counselling are radically different. Focal lesions correspond to somatic defects which are totally cured by limited pancreatic resection, whereas diffuse lesions require a subtotal pancreatectomy exposing to high risk of diabetes mellitus. Diffuse lesions are due to functional abnormalities involving several genes and different transmission forms. Recessively inherited PHHI have been attributed to homozygote mutations for the beta-cell sulfonylurea receptor (SURI) or the inward-rectifying potassium-channel (Kir6.2) genes. Dominantly inherited PHHI can implicate the glucokinase gene, particularly when PHHI is associated with diabetes, the glutamate dehydrogenase gene when hyperammonaemia is associated, or another locus.

KW - Adenoma, islet cell

KW - Hyperinsulinism

KW - Hypoglycemia

KW - Infant

KW - Islet of Langherans

KW - Pancreas

KW - Pancreatic diseases

UR - http://www.scopus.com/inward/record.url?scp=0032254148&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032254148&partnerID=8YFLogxK

U2 - 10.1016/S0929-693X(99)80055-4

DO - 10.1016/S0929-693X(99)80055-4

M3 - Articolo

C2 - 9885743

AN - SCOPUS:0032254148

VL - 5

SP - 1347

EP - 1352

JO - Archives de Pediatrie

JF - Archives de Pediatrie

SN - 0929-693X

IS - 12

ER -